Year |
Citation |
Score |
2015 |
Cholkar K, Gunda S, Earla R, Pal D, Mitra AK. Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery. Aaps Pharmscitech. 16: 610-22. PMID 25425389 DOI: 10.1208/S12249-014-0244-2 |
0.564 |
|
2014 |
Cholkar K, Hariharan S, Gunda S, Mitra AK. Optimization of dexamethasone mixed nanomicellar formulation. Aaps Pharmscitech. 15: 1454-67. PMID 24980081 DOI: 10.1208/S12249-014-0159-Y |
0.629 |
|
2014 |
Gunda S, Earla R, Cholkar K, Mitra AK. Pharmacokinetic studies and LC-MS/MS method development of ganciclovir and dipeptide monoester prodrugs in Sprague Dawley rats. European Journal of Drug Metabolism and Pharmacokinetics. PMID 24943988 DOI: 10.1007/S13318-014-0200-2 |
0.493 |
|
2012 |
Earla R, Cholkar K, Gunda S, Earla RL, Mitra AK. Bioanalytical method validation of rapamycin in ocular matrix by QTRAP LC-MS/MS: application to rabbit anterior tissue distribution by topical administration of rapamycin nanomicellar formulation. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 908: 76-86. PMID 23122404 DOI: 10.1016/J.Jchromb.2012.09.014 |
0.468 |
|
2010 |
Boddu SH, Gunda S, Earla R, Mitra AK. Ocular microdialysis: a continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye. Bioanalysis. 2: 487-507. PMID 21083257 DOI: 10.4155/Bio.10.2 |
0.703 |
|
2009 |
Hariharan S, Gunda S, Mishra GP, Pal D, Mitra AK. Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids. Pharmaceutical Research. 26: 1270-82. PMID 18958406 DOI: 10.1007/S11095-008-9741-X |
0.68 |
|
2008 |
Katragadda S, Gunda S, Hariharan S, Mitra AK. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. International Journal of Pharmaceutics. 359: 15-24. PMID 18472234 DOI: 10.1016/J.Ijpharm.2008.03.015 |
0.624 |
|
2007 |
Janoria KG, Gunda S, Boddu SH, Mitra AK. Novel approaches to retinal drug delivery. Expert Opinion On Drug Delivery. 4: 371-88. PMID 17683251 DOI: 10.1517/17425247.4.4.371 |
0.661 |
|
2006 |
Gunda S, Hariharan S, Mitra AK. Corneal absorption and anterior chamber pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV): in vivo comparative evaluation of these prodrugs with Val-GCV and GCV in rabbits. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 22: 465-76. PMID 17238815 DOI: 10.1089/Jop.2006.22.465 |
0.63 |
|
2006 |
Hariharan S, Janoria KG, Gunda S, Zhu X, Pal D, Mitra AK. Identification and functional expression of a carrier-mediated riboflavin transport system on rabbit corneal epithelium. Current Eye Research. 31: 811-24. PMID 17050273 DOI: 10.1080/02713680600899655 |
0.675 |
|
2006 |
Anand BS, Katragadda S, Gunda S, Mitra AK. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits. Molecular Pharmaceutics. 3: 431-40. PMID 16889437 DOI: 10.1021/Mp0498998 |
0.639 |
|
2005 |
Majumdar S, Gunda S, Pal D, Mitra AK. Functional activity of a monocarboxylate transporter, MCT1, in the human retinal pigmented epithelium cell line, ARPE-19. Molecular Pharmaceutics. 2: 109-17. PMID 15804185 DOI: 10.1021/Mp0499050 |
0.618 |
|
2004 |
Jain-Vakkalagadda B, Pal D, Gunda S, Nashed Y, Ganapathy V, Mitra AK. Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Molecular Pharmaceutics. 1: 338-46. PMID 16026003 DOI: 10.1021/Mp0499499 |
0.544 |
|
2004 |
Dey S, Gunda S, Mitra AK. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption. The Journal of Pharmacology and Experimental Therapeutics. 311: 246-55. PMID 15175422 DOI: 10.1124/Jpet.104.069583 |
0.636 |
|
2003 |
Majumdar S, Gunda S, Mitra A. Functional expression of a sodium dependent nucleoside transporter on rabbit cornea: Role in corneal permeation of acyclovir and idoxuridine. Current Eye Research. 26: 175-83. PMID 12815545 DOI: 10.1076/Ceyr.26.3.175.14895 |
0.638 |
|
Show low-probability matches. |